Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 7;14(1):130.
doi: 10.1186/s13023-019-1107-4.

Rendu-Osler-Weber disease: a gastroenterologist's perspective

Affiliations
Review

Rendu-Osler-Weber disease: a gastroenterologist's perspective

Annalisa Tortora et al. Orphanet J Rare Dis. .

Abstract

Hereditary hemorrhagic teleangectasia (HHT, or Rendu-Osler-Weber disease) is a rare inherited syndrome, characterized by arterio-venous malformations (AVMs or Telangiectasia). The most important and common manifestation is nose bleeds (epistaxis). The telangiectasias (small AVMs) are most evident on the lips, tongue, buccal mucosa, face, chest, and fingers, however; large arterio-venous malformations can also occur in the lungs, liver, pancreas, or brain. Telangiectasias in the upper gastrointestinal tract are known to occur, however data regarding possible small-bowel involvement is limited due to technical difficulties in visualizing the entire gastrointestinal tract. The occurrence of AVMs in the stomach and small bowel can result in chronic bleeding and anaemia. Less frequently, this may occur due to bleeding from oesophageal varices, as patients with HHT can develop hepatic parenchymal AVMs or vascular shunts which cause hepatic cirrhosis and portal hypertension. Gastroenterologists have a crucial role in the management of these patients, however difficulties remain in the detection and management of complications of HHT in the gastrointestinal tract.

Keywords: Anemia; Gastrointestinal bleeding; Hereditary hemorrhagic teleangectasia; Rendu-Osler-weber syndrome.

PubMed Disclaimer

Conflict of interest statement

We declare no commercial, personal, political, intellectual or religious conflict of interests.

Similar articles

Cited by

References

    1. Canzonieri C, Centenara L, Ornati F, Pagella F, Matti E, Alvisi C, Danesino C, Perego M, Olivieri C. Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. Genet Med. 2014;16:3–10. doi: 10.1038/gim.2013.62. - DOI - PubMed
    1. McDonald J, Pyeritz RE. Hereditary Hemorrhagic Telangiectasia [Internet]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, Bird TD, Ledbetter N, Mefford HC, Smith RJ, Stephens K. GeneReviews(®). Seattle (WA): University of Washington, Seattle; 1993 [cited 2017 Mar 11]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1351/
    1. Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med. 2014;5:191–206. - PMC - PubMed
    1. Boza JC, Dorn TV, de OFB, Bakos RM. Case for diagnosis. Hereditary Hemorrhagic Telangiectasia. An Bras Dermatol. 2014;89:999–1001. doi: 10.1590/abd1806-4841.20143232. - DOI - PMC - PubMed
    1. Ingrosso M, Sabbà C, Pisani A, Principi M, Gallitelli M, Cirulli A, Francavilla A. Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study. Endoscopy. 2004;36:1074–1079. doi: 10.1055/s-2004-826045. - DOI - PubMed

LinkOut - more resources